scispace - formally typeset
T

Takashi Yurikusa

Publications -  14
Citations -  161

Takashi Yurikusa is an academic researcher. The author has contributed to research in topics: Chemoradiotherapy & Mucositis. The author has an hindex of 6, co-authored 10 publications receiving 118 citations.

Papers
More filters
Journal ArticleDOI

Risk factors for aspiration pneumonia after definitive chemoradiotherapy or bio-radiotherapy for locally advanced head and neck cancer: a monocentric case control study.

TL;DR: The cause-specific incidence and clinical risk factors for aspiration pneumonia after definitive CRT or BRT were investigated in patients with locally advanced HNC and a predictive model was constructed that may be useful for identifying patients at high risk of aspiration pneumonia.
Journal ArticleDOI

Multicenter phase II study of an oral care program for patients with head and neck cancer receiving chemoradiotherapy

TL;DR: A systematic oral care program alone is insufficient to decrease the incidence of severe OM in patients with HNC being treated with chemoradiotherapy, however, systematic Oral care programs may indirectly improve treatment compliance by decreasing infection risk.
Journal ArticleDOI

Mandible reconstruction using the calcium-sulphate three-dimensional model and rubber stick: A new method, 'mould technique', for more accurate, efficient and simplified fabrication *

TL;DR: The refinement of mandible reconstruction after tumour ablative surgery can be achieved with a prefabricated plate through the use of a calcium-sulphate 3D model, which enables more accurate, faster and simplified fabrication of reconstruction plates, thus leading to satisfactory functional and cosmetic results.
Journal ArticleDOI

Prospective phase II study evaluating the efficacy of swallow ability screening tests and pneumonia prevention using a team approach for elderly patients with gastric cancer.

TL;DR: Although the screening tests adopted here were not sufficient to identify patients at high risk of aspiration pneumonia, perioperative interventions using a team approach might be effective in reducing the incidence of PP in elderly patients with gastric cancer.
Journal ArticleDOI

Distinctive mucositis and feeding-tube dependency in cetuximab plus radiotherapy for head and neck cancer

TL;DR: Prophylactic percutaneous endoscopic gastrostomy is recommended because most patients receiving cetuximab and radiotherapy for locally advanced head and neck squamous cell carcinoma have Grade ≥ 3 mucositis with distinctive features.